Switch theme
Sign up to access all valuation multiples
Median Technologies is engaged in providing medical imaging products and services for diagnosing and monitoring cancer patients in both routine clinical practice and clinical drug development. The firm intends to target the oncology clinical trials market and the cancer patient care market. It developed software-based tools that are integrated into a clinical application portfolio called Lesion Management Solutions. The company has two platforms, iSee for imaging services in clinical trials and iBiopsy for non-invasive diagnostic tests based on imaging for the treatment of patients suffering from cancer and other chronic diseases. Its geographical segments are France, the USA/Canada, the United Kingdom, China, and Other countries.
2002
169
LTM Revenue $26.0M
LTM EBITDA -$23.2M
$63.8M
Benchmark forward-looking revenue and EBITDA valuation multiples across generative AI, climate tech, semiconductors, online marketplaces, vertical SaaS and 220 more verticals.
Median Technologies has a last 12-month revenue of $26.0M and a last 12-month EBITDA of -$23.2M.
In the most recent fiscal year, Median Technologies achieved revenue of $23.9M and an EBITDA of -$21.3M.
Median Technologies expects next 12-month revenue of XXX and NTM EBITDA of XXX
See Median Technologies valuation multiples based on analyst estimates| FY 2023 | FY 2024 | FY 2025 | LTM | NTM | |
|---|---|---|---|---|---|
| Revenue | $23.9M | $24.6M | XXX | XXX | XXX |
| Gross Profit | $21.9M | $26.2M | XXX | XXX | XXX |
| Gross Margin | 92% | 107% | XXX | XXX | XXX |
| EBITDA | -$21.3M | -$24.1M | XXX | XXX | XXX |
| EBITDA Margin | -89% | -98% | XXX | XXX | XXX |
| Net Profit | -$20.7M | -$21.7M | XXX | XXX | XXX |
| Net Margin | -87% | -88% | XXX | XXX | XXX |
| Net Debt | n/a | n/a | XXX | XXX | XXX |
Financial data powered by Morningstar, Inc.
As of April 18, 2025, Median Technologies's stock price is EUR 2 (or $3).
Median Technologies has current market cap of EUR 46.8M (or $50.2M), and EV of EUR 59.4M (or $63.8M).
See Median Technologies trading valuation data| EV | Market Cap | Price 1D | Price 1M | Price 3M | Price 12M | EPS |
|---|---|---|---|---|---|---|
| $63.8M | $50.2M | XXX | XXX | XXX | XXX | $-1.25 |
Sign up to access valuation multiples like growth-adjusted P/E, next 12-month EV/Revenue, EBITDA multiples by industry and many more
Sign UpAs of April 18, 2025, Median Technologies has market cap of $50.2M and EV of $63.8M.
Median Technologies's trades at 2.5x LTM EV/Revenue multiple, and -2.8x LTM EBITDA.
Analysts estimate Median Technologies's 2025E EV/Revenue multiple at XXX and 2025E EV/EBITDA multiple at XXX
See valuation multiples for Median Technologies and 10K+ public comps| FY 2024 | FY 2025E | FY 2026E | FY 2027E | |
|---|---|---|---|---|
| EV | $63.8M | XXX | XXX | XXX |
| EV/Revenue | 2.6x | XXX | XXX | XXX |
| EV/EBITDA | -2.6x | XXX | XXX | XXX |
| P/E | -1.9x | XXX | XXX | XXX |
| P/E/Growth | n/a | XXX | XXX | XXX |
| EV/FCF | -2.7x | XXX | XXX | XXX |
Valuation data powered by FactSet, Inc. and Morningstar, Inc.
Access all public comps and forward-looking valuation multiples like EV/Revenue in 2025, based on equity research analyst estimates.
Sign UpMedian Technologies's NTM/LTM revenue growth is 23%
Median Technologies's revenue per employee for the last fiscal year averaged $0.1M, while opex per employee averaged $0.3M for the same period.
Over next 12 months, Median Technologies's ratio of sales and marketing spend to revenue is estimated to be XXX , while its R&D spend to revenue to be XXX .
Analysts estimate Median Technologies's 2025E EV/Revenue multiple at XXX and 2025E EV/EBITDA multiple at XXX
See operational valuation multiples for Median Technologies and other 10K+ public comps| FY 2024 | NTM | FY 2025E | FY 2026E | FY 2027E | |
|---|---|---|---|---|---|
| Revenue Growth | 3% | XXX | XXX | XXX | XXX |
| EBITDA Margin | -98% | XXX | XXX | XXX | XXX |
| EBITDA Growth | 13% | XXX | XXX | XXX | XXX |
| Rule of 40 (SaaS-only) | -75% | XXX | XXX | XXX | XXX |
| Revenue per Employee | $0.1M | XXX | XXX | XXX | XXX |
| Opex per Employee | $0.3M | XXX | XXX | XXX | XXX |
| S&M Expenses to Revenue | 2% | XXX | XXX | XXX | XXX |
| G&A Expenses to Revenue | 1% | XXX | XXX | XXX | XXX |
| R&D Expenses to Revenue | n/a | XXX | XXX | XXX | XXX |
| Opex to Revenue | 207% | XXX | XXX | XXX | XXX |
Valuation data powered by FactSet, Inc. and Morningstar, Inc.
Benchmark public comps and private revenue and EBITDA valuation multiples across GRC software, cloud infrastructure, DevOps, online marketplaces and so much more!
| EV/Revenue | EV/EBITDA | |||||
|---|---|---|---|---|---|---|
| 2025E | 2026E | 2027E | 2025E | 2026E | 2027E | |
| Philips | XXX | XXX | XXX | XXX | XXX | XXX |
| Perspective Therapeutics | XXX | XXX | XXX | XXX | XXX | XXX |
| SmartVest | XXX | XXX | XXX | XXX | XXX | XXX |
| InfuSystem | XXX | XXX | XXX | XXX | XXX | XXX |
| Myomo | XXX | XXX | XXX | XXX | XXX | XXX |
| XXXXXXXX | XXX | XXX | XXX | XXX | XXX | XXX |
| XXXXXXXX | XXX | XXX | XXX | XXX | XXX | XXX |
Valuation data powered by FactSet, Inc.
Median Technologies acquired XXX companies to date.
Last acquisition by Median Technologies was XXXXXXXX, XXXXX XXXXX XXXXXX . Median Technologies acquired XXXXXXXX for XXX (EV/Revenue multiple of XXX ).
See M&A valuation multiples| Acquired Company | EV | EV/Revenue | EV/EBITDA |
|---|---|---|---|
| XXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXX | XXX | XXX | XXX |
Sign up to see revenue and EBITDA valuation multiples for 60K+ M&A deals.
Sign Up| When was Median Technologies founded? | Median Technologies was founded in 2002. |
| Where is Median Technologies headquartered? | Median Technologies is headquartered in France. |
| How many employees does Median Technologies have? | As of today, Median Technologies has 169 employees. |
| Who is the CEO of Median Technologies? | Median Technologies's CEO is Mr. Fredrik Brag. |
| Is Median Technologies publicy listed? | Yes, Median Technologies is a public company listed on PAR. |
| What is the stock symbol of Median Technologies? | Median Technologies trades under ALMDT ticker. |
| When did Median Technologies go public? | Median Technologies went public in 2011. |
| Who are competitors of Median Technologies? | Similar companies to Median Technologies include e.g. Philips, Perspective Therapeutics, SmartVest, InfuSystem. |
| What is the current market cap of Median Technologies? | Median Technologies's current market cap is $50.2M |
| What is the current revenue of Median Technologies? | Median Technologies's last 12-month revenue is $26.0M. |
| What is the current EBITDA of Median Technologies? | Median Technologies's last 12-month EBITDA is -$23.2M. |
| What is the current EV/Revenue multiple of Median Technologies? | Current revenue multiple of Median Technologies is 2.5x. |
| What is the current EV/EBITDA multiple of Median Technologies? | Current EBITDA multiple of Median Technologies is -2.8x. |
| What is the current revenue growth of Median Technologies? | Median Technologies revenue growth between 2023 and 2024 was 3%. |
| Is Median Technologies profitable? | Yes, Median Technologies is EBITDA-positive (as of the last 12 months). |
Get access to always up-to-date, precisely categorized 70K+ public and private valuation multiples, across tech and beyond.
